{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:42:15Z","timestamp":1648676535387},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/sap.0b013e3182583ee6","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T11:21:12Z","timestamp":1355484072000},"page":"652-653","source":"Crossref","is-referenced-by-count":3,"title":["Case Report"],"prefix":"10.1097","volume":"71","author":[{"given":"Kristen E.","family":"Elstner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick K.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-8140(96)01880-4","article-title":"Wound healing following radiation therapy: a review.","volume":"2","author":"Tibbs","year":"1997","journal-title":"Radiother Oncol"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","article-title":"FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme.","volume":"14","author":"Cohen","year":"2009","journal-title":"Oncologist"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/SAP.0b013e3181828141","article-title":"A review on bevacizumab and surgical wound healing: an important warning to all surgeons.","volume":"62","author":"Gordon","year":"2009","journal-title":"Ann Plast Surg"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3171\/2010.10.JNS101042","article-title":"Impact of bevacizumab chemotherapy on craniotomy wound healing.","volume":"114","author":"Clark","year":"2011","journal-title":"J Neurosurg"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2146\/ajhp080455","article-title":"Understanding and managing the possible adverse effects associated with bevacizumab.","volume":"66","author":"Shord","year":"2009","journal-title":"Am J Health-Syst Pharm"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jso.20938","article-title":"Spontaneous, delayed colon and rectal anastomotic complications associated with bevacizumab therapy.","volume":"97","author":"August","year":"2008","journal-title":"J Surg Oncol"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jso.21447","article-title":"9. Deshaies I, Malka D, Soria J-C, et al. Antiangiogenic agents and late anastomotic complications.","volume":"101","year":"2010","journal-title":"J Surg Oncol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0b013e3182583ee6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:22:23Z","timestamp":1620973343000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000637-201312000-00008"}},"subtitle":["Management of Persistent Dural Anastomotic Dehiscence in a Patient Treated With Bevacizumab"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0b013e3182583ee6","relation":{},"ISSN":["0148-7043"],"issn-type":[{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}